Showing results (161-170 of 212) with videos related to
Sort By:
Pageof 22
Leukemia|February 28, 2018
An "off-the-shelf" fratricide-resistant CAR-T for the treatment of T cell hematologic malignanciesMatthew L Cooper, Jaebok Choi, Karl Staser, et al.Leukemia|November 17, 2025
Oncogenic activation of EVC/EVC2 defines a therapeutically targetable subset of acute myeloid leukemiaPinpin Sui, Ying Li, Juyeong Hong, et al.Pediatric Research|February 28, 2009
Ras dependent paracrine secretion of osteopontin by Nf1+/- osteoblasts promote osteoclast activation in a neurofibromatosis type I murine modelHuijie Li, Yaling Liu, Qi Zhang, et al.Plos One|March 19, 2015
Dystrophic spinal deformities in a neurofibromatosis type 1 murine modelSteven D Rhodes, Wei Zhang, Dalong Yang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2019
Subsequent Neoplasms After a Primary Tumor in Individuals With Neurofibromatosis Type 1Smita Bhatia, Yanjun Chen, F Lennie Wong, et al.Pharmacological Research|February 4, 2024
New Ref-1/APE1 targeted inhibitors demonstrating improved potency for clinical applications in multiple cancer typesSilpa Gampala, Hye-Ran Moon, Randall Wireman, et al.Gastroenterology|December 23, 2025
Depletion of Fibrinogen Suppresses Growth of Primary Tumors and Metastasis of Pancreatic Ductal AdenocarcinomaNayela N Chowdhury, Dana K Mitchell, Kadri Kangro, et al.Leukemia|January 26, 2026
Phf6 truncating mutation drives leukemogenesis via disrupted epigenetic regulation in miceYing Guo, Pinpin Sui, Hui Yang, et al.Stem Cell Investigation|July 1, 2016
Interleukin 8/KC enhances G-CSF induced hematopoietic stem/progenitor cell mobilization in Fancg deficient miceYan Li, Wen Xing, Yong-Zheng He, et al.Human Molecular Genetics|July 19, 2013
Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient miceRicha Sharma, Xiaohua Wu, Steven D Rhodes, et al.Pageof 22